zeatin has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SG; Choi, SJ; Chun, JY; Heo, HJ; Jeong, CH; Kim, YJ; Lee, J; Shin, DH | 1 |
| Cho, HY; Heo, HJ; Hong, B; Hong, SC; Kim, EK; Kim, HK; Shin, DH | 1 |
2 other study(ies) available for zeatin and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Zeatin prevents amyloid beta-induced neurotoxicity and scopolamine-induced cognitive deficits.
Topics: Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Animals; Antioxidants; Behavior, Animal; Brain; Cholinergic Antagonists; Cognition Disorders; Learning; Lipid Peroxidation; Memory; Mice; Mice, Inbred ICR; Morus; Neurotoxicity Syndromes; PC12 Cells; Phytotherapy; Plant Extracts; Plant Leaves; Protective Agents; Rats; Reactive Oxygen Species; Scopolamine; Zeatin | 2009 |
Inhibitory effect of zeatin, isolated from Fiatoua villosa, on acetylcholinesterase activity from PC12 cells.
Topics: Acetylcholinesterase; Alzheimer Disease; Animals; Cholinesterase Inhibitors; Chromatography; Humans; PC12 Cells; Plants, Medicinal; Rats; Zeatin | 2002 |